Stereotactic conformal radiotherapy of hepatic metastases: clinical analysis of 8 cases

Table 1 Clinical data of hepatic metastases with stereotactic conformal radiotherapy

	Patient No.
	1	2	3	4	5	6	7	8
Sex (M/F)	M	M	F	F	F	M	F	M
Age (years)	59	46	49	54	67	61	49	58
Primary tumor	Colon	Lung	Breast	Breast	Preventriculus	Stomach	Breast	Cholecyst
Number of irradiated tumor	1	3	1	4	2	5	4	1
Volume of clinical	34.5	1.9, 1.5	14.8	5.1, 0.6	18.4	232, 134.1	30.7, 11.6	120.3
target (cm3)		2.1		0.9, 0.9	16.7	75.2, 7.7, 23.7	3.3, 1.5
Prescribed dose (Gy)	5.00	4.50	5.00	5.00	5.00	4.00	6.00	6.50
Number of fractions	3	8	8	5	2	7	7	7
KPS before treatment	80	40	90	90	20	40	40	70
KPS after treatment	80	50	100	100	30	50	70	90
Size of tumor after irradiation	NC	PD	CR	CR	NC	PR	PR	PR
Time period of follow-up	8	4	6	6	2	3	3	2
Time period after irradiation (months)	Unknown	3.3	6	6	1.5	2.3	3	2